Key Takeaways: Ozempic and Wegovy contain semaglutide, a GLP-1 medication prescribed for chronic weight management when clinically appropriate Once-weekly injections help reduce appetite, improve fullness, and support sustainable weight loss Physician-supervised program with personalized dosing and ongoing monitoring Available in Miami, FL via telehealth and in-office consultations Insurance verification support and transparent self-pay options available Prescription required after medical evaluation
Kinase adds phosphate groups to tau , but the phosphatase PP2A removes them
Learn More A once-weekly, lower-dose dual agonist (GLP-1/GIP) designed for a gentler start and to minimize side effects
Krhus ML, Brnden A, Forman JL, et al
Zepbound (tirzepatide) FDA-approved for chronic weight management using the same BMI criteria, and, since December 20, 2024, for moderate-to-severe obstructive sleep apnea in adults with obesity